Search

everythinglearnresearchcommunity

for

Search:↓

The document concludes that treating androgen excess needs patience, managing expectations is important, and many drugs used are not officially approved, suggesting cosmetic options for mild cases.

Women with hyperandrogenism have higher androgen levels and lower SHBG, which may contribute to conditions like excessive hair growth and early puberty.

Some birth control pills can cause hair loss, and switching to ones with less androgen should help.

Women with non-classic congenital adrenal hyperplasia have higher risk for heart and metabolic problems.

PCOS is complex, affects many, and requires informed management and lifestyle changes.

Early treatment of acne is crucial to prevent scarring and psychological effects.

Women with PCOS have altered brain structure and reduced cognitive performance.

The document concludes that skin and nail changes can indicate various underlying health conditions.

Treat hair loss in postmenopausal women with diet, avoiding certain drugs, and using medications like minoxidil or finasteride.

Hirsutism is mainly caused by high androgen levels or sensitivity, with PCOS being the most common cause.

Women with PCOS in Nigeria have higher heart risk markers, needing early heart health checks.

Electrical stimulation with a low-calorie diet reduces appetite, weight, and blood pressure in obese people with sleep apnea.

Spexin levels are lower in PCOS patients and linked to metabolic and hormonal issues.

PCOS is common in young women, especially those aged 21-30, and often involves symptoms like irregular periods, weight gain, and acne.

Certain gene variations may increase the risk of PCOS in South Indian women.

Metformin improves early signs of heart disease in women with PCOS and raises apelin levels, but doesn't significantly change artery thickness.

The document concludes that accurate diagnosis of male and female gonadal disorders is crucial for effective treatment and better patient outcomes.

Nonclassic congenital adrenal hyperplasia is a common genetic disorder that can cause a range of symptoms and requires personalized treatment.

The hypothesis suggests that PCOS may start early in life due to genetic and environmental factors, influencing future reproductive and metabolic problems.

Women with PCOS have more body fat and thicker fat layers in certain abdominal areas than women without PCOS.

Obese women with PCOS show a male-like pattern in certain fat tissue gene expressions.

Systemic retinoids are effective for psoriasis but have side effects; benefits may outweigh risks, especially when reducing cancer risks from other treatments.

A new method can almost perfectly distinguish adenomyosis from similar conditions using blood tests.

Women with PCOS and androgenic alopecia have different triglyceride metabolism compared to those without hair loss.

The guidelines recommend informed consent for gender-affirming treatments and stress the importance of personalized, culturally sensitive care for transgender individuals.

The guideline recommends mental health involvement in diagnosing gender identity disorder and outlines hormone and surgical treatment protocols, emphasizing safety, informed consent, and long-term monitoring.

Women with PCOS should be screened for heart disease risk and manage their health to prevent it.

The secretions of mesenchymal stem cells could be used for healing without using the cells themselves.

Polycystic ovary syndrome affects about 6-10% of women, with varying symptoms and the need for standardized global definitions.

PCOS affects a similar percentage of Black and White women in the Southeastern United States.